Agilent Technologies Net Income 2010-2024 | A
Agilent Technologies annual/quarterly net income history and growth rate from 2010 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
- Agilent Technologies net income for the quarter ending October 31, 2024 was $0.351B, a 26.11% decline year-over-year.
- Agilent Technologies net income for the twelve months ending October 31, 2024 was $1.289B, a 3.95% increase year-over-year.
- Agilent Technologies annual net income for 2024 was $1.289B, a 3.95% increase from 2023.
- Agilent Technologies annual net income for 2023 was $1.24B, a 1.12% decline from 2022.
- Agilent Technologies annual net income for 2022 was $1.254B, a 3.64% increase from 2021.
| Agilent Technologies Annual Net Income (Millions of US $) |
|
|---|---|
| 2024 | $1,289 |
| 2023 | $1,240 |
| 2022 | $1,254 |
| 2021 | $1,210 |
| 2020 | $719 |
| 2019 | $1,071 |
| 2018 | $316 |
| 2017 | $684 |
| 2016 | $462 |
| 2015 | $401 |
| 2014 | $549 |
| 2013 | $734 |
| 2012 | $1,153 |
| 2011 | $1,012 |
| 2010 | $684 |
| 2009 | $-31 |
| Agilent Technologies Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2024-10-31 | $351 |
| 2024-07-31 | $282 |
| 2024-04-30 | $308 |
| 2024-01-31 | $348 |
| 2023-10-31 | $475 |
| 2023-07-31 | $111 |
| 2023-04-30 | $302 |
| 2023-01-31 | $352 |
| 2022-10-31 | $368 |
| 2022-07-31 | $329 |
| 2022-04-30 | $274 |
| 2022-01-31 | $283 |
| 2021-10-31 | $442 |
| 2021-07-31 | $264 |
| 2021-04-30 | $216 |
| 2021-01-31 | $288 |
| 2020-10-31 | $222 |
| 2020-07-31 | $199 |
| 2020-04-30 | $101 |
| 2020-01-31 | $197 |
| 2019-10-31 | $194 |
| 2019-07-31 | $191 |
| 2019-04-30 | $182 |
| 2019-01-31 | $504 |
| 2018-10-31 | $195 |
| 2018-07-31 | $236 |
| 2018-04-30 | $205 |
| 2018-01-31 | $-320 |
| 2017-10-31 | $177 |
| 2017-07-31 | $175 |
| 2017-04-30 | $164 |
| 2017-01-31 | $168 |
| 2016-10-31 | $126 |
| 2016-07-31 | $124 |
| 2016-04-30 | $91 |
| 2016-01-31 | $121 |
| 2015-10-31 | $140 |
| 2015-07-31 | $111 |
| 2015-04-30 | $87 |
| 2015-01-31 | $63 |
| 2014-10-31 | $16 |
| 2014-07-31 | $147 |
| 2014-04-30 | $139 |
| 2014-01-31 | $195 |
| 2013-10-31 | $211 |
| 2013-07-31 | $168 |
| 2013-04-30 | $166 |
| 2013-01-31 | $179 |
| 2012-10-31 | $425 |
| 2012-07-31 | $243 |
| 2012-04-30 | $255 |
| 2012-01-31 | $230 |
| 2011-10-31 | $289 |
| 2011-07-31 | $330 |
| 2011-04-30 | $200 |
| 2011-01-31 | $193 |
| 2010-10-31 | $292 |
| 2010-07-31 | $205 |
| 2010-04-30 | $108 |
| 2010-01-31 | $79 |
| 2009-10-31 | $25 |
| 2009-07-31 | $-19 |
| 2009-04-30 | $-101 |
| 2009-01-31 | $64 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $43.273B | $6.510B |
| Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $221.889B | 27.39 |
| Boston Scientific (BSX) | United States | $150.861B | 43.37 |
| Stryker (SYK) | United States | $149.166B | 32.10 |
| EssilorLuxottica (ESLOY) | France | $125.458B | 0.00 |
| Medtronic (MDT) | Ireland | $116.457B | 17.30 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.799B | 0.00 |
| Haleon (HLN) | United Kingdom | $42.868B | 27.85 |
| GE HealthCare Technologies (GEHC) | United States | $40.342B | 20.92 |
| ResMed (RMD) | United States | $34.670B | 26.72 |
| Terumo (TRUMY) | Japan | $27.627B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $25.924B | 19.84 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.795B | 13.88 |
| Insulet (PODD) | United States | $19.527B | 77.76 |
| Baxter (BAX) | United States | $16.625B | 10.82 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.096B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.103B | 34.34 |
| Sunny Optical Technology (SNPTF) | China | $9.976B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.961B | 40.08 |
| Demant (WILYY) | Denmark | $8.994B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.432B | 14.94 |
| ICU Medical (ICUI) | United States | $4.024B | 38.31 |
| Prestige Consumer Healthcare (PBH) | United States | $3.793B | 18.86 |
| Envista Holdings (NVST) | United States | $3.531B | 26.31 |
| Haemonetics (HAE) | United States | $3.468B | 16.92 |
| Perrigo (PRGO) | Ireland | $3.398B | 10.00 |
| GN Store Nord (GNNDY) | Denmark | $3.105B | 19.91 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.923B | 18.81 |
| Neogen (NEOG) | United States | $2.486B | 28.65 |
| LeMaitre Vascular (LMAT) | United States | $2.179B | 52.97 |
| AtriCure (ATRC) | United States | $1.944B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.483B | 25.96 |
| AdaptHealth (AHCO) | United States | $1.456B | 10.40 |
| InMode (INMD) | Israel | $1.445B | 8.69 |
| BioLife Solutions (BLFS) | United States | $1.267B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.245B | 0.00 |
| Owens & Minor (OMI) | United States | $1.098B | 8.58 |
| Evolus (EOLS) | United States | $0.885B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.883B | 15.58 |
| Curaleaf Holdings (CURLF) | Canada | $0.866B | 0.00 |
| CeriBell (CBLL) | United States | $0.824B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.684B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.567B | 24.98 |
| Omeros (OMER) | United States | $0.500B | 0.00 |
| Surmodics (SRDX) | United States | $0.487B | 0.00 |
| Valneva SE (VALN) | France | $0.470B | 0.00 |
| SNDL (SNDL) | Canada | $0.457B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.454B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.449B | 0.00 |
| ZimVie (ZIMV) | United States | $0.382B | 32.19 |
| Quanterix (QTRX) | United States | $0.354B | 0.00 |
| Cerus (CERS) | United States | $0.347B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.319B | 30.33 |
| Sanara MedTech (SMTI) | United States | $0.318B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.300B | 20.10 |
| Biote (BTMD) | United States | $0.277B | 6.06 |
| Canopy Growth (CGC) | Canada | $0.260B | 0.00 |
| Zynex (ZYXI) | United States | $0.250B | 52.27 |
| Sanuwave Health (SNWV) | United States | $0.237B | 3.33 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.226B | 0.00 |
| High Tide (HITI) | Canada | $0.226B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.208B | 15.50 |
| Aurora Cannabis (ACB) | Canada | $0.200B | 0.00 |
| Brainsway (BWAY) | Israel | $0.198B | 105.10 |
| Organigram Holdings (OGI) | Canada | $0.189B | 0.00 |
| MacroGenics (MGNX) | United States | $0.188B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.168B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.156B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.141B | 17.76 |
| Quipt Home Medical (QIPT) | United States | $0.139B | 0.00 |
| Jin Medical (ZJYL) | China | $0.138B | 0.00 |
| Fonar (FONR) | United States | $0.100B | 11.25 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| Veru (VERU) | United States | $0.081B | 0.00 |
| InterCure (INCR) | Israel | $0.074B | 0.00 |
| Exagen (XGN) | United States | $0.071B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.066B | 34.00 |
| Jushi Holdings (JUSHF) | United States | $0.065B | 0.00 |
| INLIF (INLF) | $0.062B | 0.00 | |
| Ayr Wellness (AYRWF) | United States | $0.056B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.055B | 0.00 |
| Apyx Medical (APYX) | United States | $0.054B | 0.00 |
| United-Guardian (UG) | United States | $0.053B | 15.18 |
| Modular Medical (MODD) | United States | $0.052B | 0.00 |
| ImmuCell (ICCC) | United States | $0.048B | 0.00 |
| Safety Shot (SHOT) | United States | $0.030B | 0.00 |
| Nephros (NEPH) | United States | $0.017B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.016B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.015B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.011B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| Sharps Technology (STSS) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |